CDKN2A/B HD are identified in approximately 22% of IDH-mutant astrocytomas [8] and are thought to lead to the loss of cell cycle control and promote cell proliferation [9]. This evidence concerns the gene HTT and astrocytoma (excluding glioblastoma).